Free Trial
NASDAQ:TLSIW

TriSalus Life Sciences (TLSIW) Stock Price, News & Analysis

TriSalus Life Sciences logo
$1.22 -0.35 (-22.29%)
As of 04/24/2025 11:56 AM Eastern

About TriSalus Life Sciences Stock (NASDAQ:TLSIW)

Key Stats

Today's Range
$1.22
$1.50
50-Day Range
$1.16
$1.70
52-Week Range
$0.42
$2.24
Volume
332 shs
Average Volume
3,820 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TriSalus Life Sciences, Inc., a medical technology company, researches, develops, and sells drug delivery technologies and immune-oncology therapeutics for the treatment of liver and pancreatic cancer. The company offers Pressure Enabled Drug Delivery infusion systems, such as the TriNav infusion system, which is used in transarterial radioembolization and chemoembolization procedures for patients with liver cancer and metastases; and the Pancreatic Retrograde Venous Infusion device, which is in Phase 1 clinical trial, for locally advanced pancreatic cancer. It also develops nelitolimod, an investigational immunotherapeutic in Phase 1 clinical trial for the treatment of uveal melanoma with liver metastases, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, and locally advanced pancreatic ductal adenocarcinoma. The company serves interventional radiologists, IR technicians, medical oncologists, nursing support, value analysis committee staff, and patients through its sales representatives and sales managers. TriSalus Life Sciences, Inc. was founded in 2009 and is headquartered in Westminster, Colorado.

Receive TLSIW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TriSalus Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

TLSIW Stock News Headlines

DividendStocks for Beginners
If you’re not familiar with how to build a strong, reliable dividend portfolio… or where to begin… We’ve got the hookup for you. A young investor who’s obsessed with dividends put together a set of 5 dividend “cheat sheets” meant to take you from 0 to what could be a full blown dividend portfolio as quickly as possible… The best part? Right now, the five dividend cheat sheets are FREE
See More Headlines

TLSIW Stock Analysis - Frequently Asked Questions

TriSalus Life Sciences' stock was trading at $1.10 at the start of the year. Since then, TLSIW stock has increased by 10.9% and is now trading at $1.22.
View the best growth stocks for 2025 here
.

Shares of TLSIW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Devices
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:TLSIW
Fax
N/A
Employees
106
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$29.43 million
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:TLSIW) was last updated on 4/25/2025 by MarketBeat.com Staff
From Our Partners